High sensitivity measurement of CRP and disease progression in multiple sclerosis.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 16009907.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors measured serum C-reactive protein (CRP) serially in patients with multiple sclerosis (MS) who participated the PRISMS study using a high-sensitivity technique. CRP values were similar in patients with MS and in healthy controls but higher during MS relapses than in remission (p = 0.010). CRP levels were lower during treatment with high-dose interferon beta 1a than placebo (p = 0.035) and higher during first 12 months of study in patients who progressed by year 4 compared with stable patients (p = 0.007).
Medical subject headings
- C-Reactive Protein
- Interferon-beta
- Multiple Sclerosis